Cite
HARVARD Citation
Dias, J. et al. (n.d.). 218Novel thromboelastography point-of-care test detects all commercially available DOACs at therapeutic concentrations and classifies them as direct thrombin or factor Xa inhibitors with high consistency. European heart journal. p. . [Online].